CLL Treatment Considerations: COVID-19 and BeyondContains 4 Component(s)
The COVID-19 pandemic has affected treatment patterns for patients with CLL. Javier Munoz, MD, MS, FACP, Senior Associate Consultant in the Division of Hematology and Medical Oncology at the Mayo Clinic (Arizona) will discuss considerations for treating patients with CLL in the pandemic--including options for treatment, best timing for treatment, and any changes to the usual treatment regimen. Dr. Munoz will also explore what care may look like for patients with CLL beyond COVID-19.
Learning from COVID-19: Coping Strategies for CLL Providers & PatientsContains 4 Component(s)
The COVID-19 pandemic has heightened the distress patients with CLL are experiencing and taken its toll on providers. In this presentation, Alison Mayer Sachs, MSW, LSW, OSW-C, FAOSW, Director of Community Outreach & Cancer Support Services in the Eisenhower Lucy Curci Cancer Center at Eisenhower Medical Center will discuss the distress experienced by both patients and providers and offer solutions and ways forward.
The COVID-19 Vaccine for Patients with CLL and Other CancersContains 4 Component(s)
The speaker will discuss considerations around the COVID-19 vaccines and interpret the respective NCCN guidance for patients with CLL and other cancers.
Returning to Practice in the Post-COVID-19 Era: Hematology Disease EducationContains 4 Component(s)
Panelists will discuss considerations for resuming pre-pandemic level visits and procedures for patients with CLL, Acute , and Multiple Myeloma. Panelists will also discuss their wins and challenges with providing care to respective patients in a pandemic.
COVID-19 Implications for Cancer Clinical Research and Quality CareContains 3 Component(s)
The COVID-19 pandemic has thrown a wrench into every corner of the American healthcare system, and clinical research is no exception. In light of physical distancing and public safety recommendations, research programs have made significant adjustments, including virtual approaches to site selection and data collection and increased use of telehealth services. What lessons about clinical research can be learned during the pandemic, and what does it mean for the future of cancer research?
Financial Navigation During the COVID-19 Crisis: Tips From Financial AdvocatesContains 2 Component(s)
ACCC Financial Advocacy Network Town Hall
ASCO Survey on COVID-19 in Oncology (ASCO) RegistryContains 3 Component(s)
Join the Association of Community Cancer Centers (ACCC) and the American Society of Clinical Oncology (ASCO) for a webcast on how the COVID-19 pandemic presents a unique opportunity to better understand the effects of a disease outbreak on the delivery of high-quality cancer care and research.
Risk Stratification for Cancer Patients During COVID-19Contains 4 Component(s)
ACCC COVID-19 Webinar
Weathering the COVID-19 Storm: One Program's Care Coordination ExperienceContains 3 Component(s)
ACCC COVID-19 Webinar
|Access Date||Quiz Result||Score||Actions|